Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Towa Pharmaceutical Co ( (JP:4553) ) has issued an announcement.
Towa Pharmaceutical Co., Ltd. has announced a resolution to dispose of 800 treasury shares as part of a restricted stock compensation plan for its directors. This move is designed to align the directors’ compensation with the company’s performance and shareholder value, fostering a long-term increase in corporate value and strengthening shareholder-oriented management.
The most recent analyst rating on (JP:4553) stock is a Buy with a Yen4200.00 price target. To see the full list of analyst forecasts on Towa Pharmaceutical Co stock, see the JP:4553 Stock Forecast page.
More about Towa Pharmaceutical Co
Towa Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing primarily on the development and distribution of generic drugs. The company aims to enhance corporate value and shareholder engagement through strategic compensation plans and stock management.
Average Trading Volume: 133,946
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen143.6B
For detailed information about 4553 stock, go to TipRanks’ Stock Analysis page.